Author

Markus David Siegelin

Columbia University Irving Medical CenterORCID 0000-0001-7113-3634Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:metabolomics· 1 Organism:mouse· 1

Frequent Co-Authors

Aayushi MahajaniD· 1 shared Abby L. Brand· 1 shared Allison Kleinstein· 1 shared Angeliki MelaiD· 1 shared Athanassios Dovas· 1 shared Brent R. StockwelliD· 1 shared Brian Gill· 1 shared Jeffrey N. BruceiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aayushi MahajanORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintFeb 2, 2026

IDH-mutant inhibitors enhance the sensitivity of IDH1-mutant gliomas to cysteine-methionine deprivation and ferroptosis

Angeliki Mela, Abby L. Brand, Aayushi Mahajan…·Peter Canoll

This study shows that IDH1-mutant glioma cells are more sensitive to cysteine-methionine deprivation and ferroptosis inducers, and that IDH inhibitors enhance this sensitivity.

1 citation

mousemetabolomics

𝕏 PostBluesky